CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
71 research outputs found
Quantitative brain MR imaging in amyotrophic lateral sclerosis
Author
A Yagishita
Aaron M. Rulseh
+47Â more
BR Brooks
C Lomen-Hoerth
CA Sage
CA Sage
CD Good
CD Good
DM Mezzapesa
DS Goodin
E Hofmann
F Agosta
F Agosta
G Bartzokis
G Bartzokis
G Cheung
GA Rippon
H Axer
H Oba
Hana MalÃková
J Ashburner
J Ashburner
J Ashburner
J Kassubek
J Murphy
J Phukan
J Vymazal
J Vymazal
Jiřà Keller
JL Chang
Josef Vymazal
K Hirayama
M Cosottini
MJ Hecht
MJ Hecht
Otakar Keller
Petr Kulišt’ák
Petr Ridzoň
R Jech
R Rusina
Robert Jech
Robert Rusina
S Atlas
S Ngai
SM Smith
SM Smith
SM Smith
The ALS CNTF treatment study (ACTS) phase I-II Study Group
V Adams
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Re: Pharmacokinetics and pharmacodynamics of rHCNTF in rodents
Author
Abdallah
ALS CNTF Treatment Study (ACTS) Phase I-II Study Group
+10Â more
ALS CNTF Treatment Study (ACTS) Phase I-II Study Group
Curtis
Dittrich
Helgren
Ikeda
Ip
Miller
Mitsumoto
Mitsunioto
Sendtner
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease
Author
Aebischer
ALS CNTF Treatment Study (ACTS) Phase I-II Study Group
+25Â more
ALS CNTF Treatment Study (ACTS) Phase I-II Study Group
ALS CNTF Treatment Study Group
Arakawa
BDNF Study Group (Phase III)
Borasio
Brooks
Giehl
Hantai
Higgins
Kishino
Lai
Miller
Miller
Miller
Mitchell
Mitsumoto
Mitsumoto
Ochs
Oppenheim
Penn
Sagot
Sendtner
Sendtner
Sendtner
Yan
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
Author
ALS CNTF Treatment Study Group
Benoit
+8Â more
Fernando Cordido
Foster-Schubert
Gutzwiller
Li
Mekala
Moulin
Mª Luisa Isidro
Wacker
Publication venue
'MDPI AG'
Publication date
Field of study
No full text
Crossref
Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity
Author
ALS CNTF Treatment Study (ACTS) Phase I-II Study Group
Amato
+19Â more
Cederbaum
Dalakas
Dalakas
Dalakas
Engel
Gordon
Great Lakes ALS Study Group
Griggs
Kasarskis
Kaufmann
Levy
Miller
Montes
Muscle Study Group
Muscle Study Group
Rutkove
Scelsa
Sekul
Soueidan
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study)
Author
Abe K.
Acworth I. N.
+22Â more
Akio Kimura
ALS CNTF Treatment Study (ACTS) Group
ALS CNTF Treatment Study (ACTS) Phase I–II Study Group
BDNF Study Group (Phase III)
Beal M. F.
Braun S. R
Bruijn L. I.
Caroscio J. T.
Edaravone Acute Brain Infarction Study Group
Florence J.
Hiide Yoshino
Ikeda K.
Lacomblez L.
Miller R. G.
Mizuno A.
Oda E.
Ohasi Y.
Sasaki S.
Shibata N
Tohgi H.
Watanabe T.
Yamamoto T.
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis
Author
ALS CNTF Treatment study (ACTs) Phase III Study Group
Appel
+19Â more
Armon
Bensimon
Brooks
Cudkowicz
de-Carvalho
Desport
Felice
Heiman-Patterson
Kelly
Lo Coco
McComas
Miller
Mitchell
Nirmalananthan
Shefner
Shefner
Shefner
Wang
Yuen
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Psychometric validation of a patient-reported measure of physical functioning in sporadic inclusion body myositis
Author
Amato
Badrising
+17Â more
Bennell
Bruce
Catalan
Cedarbaum
Cohen
Cronbach
DeMuro
Dobloug
FDA
Griggs
Hilton-Jones
Jackson
Meyer
Nunnally
Rider
SAS Institute Inc
The ALS CNTF treatment study (ACTS) phase I-II Study Group
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Long-term control of food intake and body weight by hydrodynamics-based delivery of plasmid DNA encoding leptin or CNTF
Author
Ahima
ALS CNTF Treatment Study Group
+23Â more
Bado
Chen
Farooqi
Friedman
Fruhbeck
Gloaguen
Halaas
Henderson
Jiang
Lambert
Liu
Masuzaki
Murphy
Niwa
Ott
Pan
Pan
Smith-Kirwin
Vaisse
Xu
Zhang
Zhang
Zvonic
Publication venue
'Wiley'
Publication date
01/01/2003
Field of study
No full text
Crossref
Cerebrospinal fluid tau
Author
ALS CNTF Treatment Phase I-II Study Group
Appel
+22Â more
Blennow
Bradley
Brettschneider
Brettschneider
Brooks
Buée
Delacourte
Fischer
Goedert
Goode
Jablonka
Jiménez-Jiménez
Matsumoto
Muruyama
Ryberg
Satoh
Sjögren
Sjögren
Strong
Sunderland
Süssmuth
Süssmuth
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
1
2
3
…
last